Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Condition: HIV Lipodystrophy

NCT ID: NCT01511016

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Condition: HIV Infections

NCT ID: NCT00457665

Energy Expenditure of People Living With HIV/AIDS

Condition: HIV/AIDS; HIV Lipodystrophy Syndrome

NCT ID: NCT02530827

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Condition: HIV-Associated Lipodystrophy; HIV Infections

NCT ID: NCT00126308

HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)

Condition: HIV Infections

NCT ID: NCT01023620

HIV Fat Redistribution and the Evaluation of Brown Fat

Condition: HIV Infections

NCT ID: NCT01098045

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122668

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Condition: HIV-Associated Lipodystrophy Syndrome; HIV Infections

NCT ID: NCT00148850

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00307164

TH9507 in Patients With HIV-Associated Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00123253

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT01359917

TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy

Condition: Lipodystrophy; HIV Infections

NCT ID: NCT00608023

Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

Condition: HIV Facial Lipoatrophy

NCT ID: NCT02342223

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00646984

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00383734

Effects of Growth Hormone Releasing Hormone in HIV

Condition: HIV; HIV Lipodystrophy

NCT ID: NCT01263717

Rosiglitazone Effect on Mitochondria and Lipoatrophy

Condition: HIV Infections

NCT ID: NCT00367744

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Condition: AIDS; HIV Infections

NCT ID: NCT00100698

A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006190

Effects of IGF-I in HIV Metabolic Disease

Condition: HIV Lipodystrophy

NCT ID: NCT01329744

Artefill for the Treatment of HIV-associated Facial Lipoatrophy

Condition: HIV-facial Lipoatrophy

NCT ID: NCT02009462

Role of the Autonomic Nervous System in HIV-Lipodystrophy

Condition: HIV Infections; Lipodystrophy-Syndrome

NCT ID: NCT00149097

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

Condition: HIV Infection; Mitochondrial Dysfunction

NCT ID: NCT01194856

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135460

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135356

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Condition: HIV Infection; Antiretroviral Side Effects; Lipodystrophy Syndrome Related to HIV Infection

NCT ID: NCT01077765

Raltegravir Therapy for Women With HIV and Fat Accumulation

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00656175

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Condition: HIV Infections; HIV Lipodystrophy Syndrome

NCT ID: NCT00122655

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

Condition: HIV

NCT ID: NCT01579695

Effects of Short-term Growth Hormone in HIV-infected Patients

Condition: HIV Lipodystrophy

NCT ID: NCT00795210

Eplerenone in HIV Associated Abdominal Fat Accumulation

Condition: HIV

NCT ID: NCT01405456

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00312832

Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults

Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders

NCT ID: NCT00119379

Pilot Study of Raltegravir Lipodystrophy IISP

Condition: HIV Infection

NCT ID: NCT01164605

Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00082628

Metabolic Abnormalities in HIV-infected Persons

Condition: Lipodystrophy; HIV Infection

NCT ID: NCT01612858

SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

Condition: HIV Infection

NCT ID: NCT00225082

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy

Condition: Nonalcoholic Fatty Liver Disease; HIV

NCT ID: NCT02684591

Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

Condition: Human Immunodeficiency Virus; Lipohypertrophy

NCT ID: NCT01420523

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00119769

Therapeutic Approaches to HAART-Induced Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00461552

HIV and Fat Accumulation

Condition: HIV Infection

NCT ID: NCT01088295

A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications

Condition: HIV Infections

NCT ID: NCT00002417

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006290

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122226

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

Condition: Cardiovascular Diseases; Heart Diseases; HIV Infections; Hyperlipidemia; Hypertriglyceridemia; Insulin Resistance; Atherosclerosis

NCT ID: NCT00246376

PREventing Progression of Adipose Tissue Redistribution

Condition: HIV Infections

NCT ID: NCT00389194

Study of Lifestyle Modification in HIV Lipodystrophy

Condition: HIV; Metabolic Diseases

NCT ID: NCT00111358

Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders

NCT ID: NCT00119405

Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.

Condition: HIV; Lipodystrophy

NCT ID: NCT02258685

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Condition: HIV Infections

NCT ID: NCT01031849

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006412

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Condition: HIV Infection

NCT ID: NCT01159743

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

Condition: HIV Infections; Lipodystrophy; Insulin Resistance

NCT ID: NCT00006185

Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome

Condition: HIV Lipodystrophy

NCT ID: NCT00362440

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution

Condition: HIV Infections; Insulin Resistance

NCT ID: NCT00025753

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00662181

The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS

Condition: HIV; AIDS; Lipodystrophy; Hyperlipidemia

NCT ID: NCT00202241

Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome

Condition: HAART-induced Lipodystrophy and Metabolic Syndrome

NCT ID: NCT00140244

Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects

Condition: Acquired Immunodeficiency Syndrome; Lipodystrophy

NCT ID: NCT00172315

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

HIV Posterior Cheek Enlargement

Condition: HIV Posterior Cheek Enlargement

NCT ID: NCT01635504

Metabolomics Fingerprinting and Metabolic Dynamics After HIV Infection

Condition: HIV

NCT ID: NCT01828268

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Condition: Diabetic Retinopathy; HIV

NCT ID: NCT01591902

Study of Home-Based Resistance and Strength Training in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00111332

The Use of Nutropin Depot in HIV-Infected Adult Males

Condition: HIV Infection

NCT ID: NCT00286676

An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Condition: HIV-associated Lipodystrophy Syndrome

NCT ID: NCT01848340

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00021463

The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children

Condition: HIV Infections; HIV Wasting Syndrome; Lipodystrophy

NCT ID: NCT00006064

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00389207

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Condition: Insulin Resistance; Cardiovascular Diseases; Heart Diseases; HIV Infections; Hypertriglyceridemia; Hyperlipidemia

NCT ID: NCT00246402

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Condition: HIV Infections; Lipodystrophy; Hyperinsulinemia

NCT ID: NCT00015691

Strength Training With Vascular Occlusion in Patients Harboring With HIV/Aids

Condition: Cardiovascular Diseases

NCT ID: NCT02783417

Exercise for Patients With HIV Infections

Condition: HIV Infections; Lipodystrophy; Inflammation

NCT ID: NCT00910936

Epidermal Nerve Fiber Density, Fat and Mitochondrial Parameters in Thai HIV+ Patients on d4T and HIV- Patients

Condition: HIV

NCT ID: NCT01178684

Pathophysiological Study of Adipose Tissue of Patients Infected With HIV

Condition: HIV

NCT ID: NCT02820337

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Condition: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes

NCT ID: NCT00130286

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

Condition: HIV Infections

NCT ID: NCT00669487

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Condition: HIV Infections; HIV Seronegativity; Lipodystrophy

NCT ID: NCT00017758

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Condition: Human Immunodeficiency Virus; Facial Lipoatrophy

NCT ID: NCT00333684

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Condition: Acquired Immune Deficiency Syndrome; HIV Infections

NCT ID: NCT00872417

Long Term Treatment Interruptions

Condition: HIV Infections; AIDS

NCT ID: NCT00433056

Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00006493

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Condition: HIV Infections; Lipodystrophy; Wasting Disease

NCT ID: NCT00028314

Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART

Condition: HIV Infections; Hyperlipidemia; Exercise

NCT ID: NCT00572429

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

Condition: HIV/AIDS

NCT ID: NCT02041520

Lactate Metabolism Study in HIV Infected Persons

Condition: HIV Infections; AIDS; Lactic Acidosis; Lipodystrophy

NCT ID: NCT00202228

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Condition: HIV Infections; Lipodystrophy; Diabetes; Hyperlipidemia; Atherosclerosis

NCT ID: NCT00331448

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

Condition: Facial Lipoatrophy

NCT ID: NCT00360932

Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment

Condition: Adolescent Behavior; Hiv; Dyslipidemias

NCT ID: NCT03021889

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome; HIV Lipodystrophy Syndrome; Lipodystrophy; Dyslipidemia; Osteoporosis; Osteopenia

NCT ID: NCT00069004

Metabolism and Body Shape of Healthy Children and Children With Chronic Infections

Condition: HIV Infections; Healthy; Hyperlipidemia; Lipodystrophy

NCT ID: NCT00001142

Pravastatin for Hyperlipidaemia in HIV.

Condition: HIV Infections; Lipid Metabolism; Glucose Metabolism; Metabolic Abnormality; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00227500

Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

Condition: HIV-infection

NCT ID: NCT01407237

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

Condition: Atherosclerosis

NCT ID: NCT01519141

Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances

Condition: Lipodystrophy; Metabolic Syndrome

NCT ID: NCT02614027

Yoga for the Management of HIV-Metabolic Syndromes

Condition: HIV Infections; HIV Metabolic Cardiovascular Syndrome; HIV Lipodystrophy; HIV Metabolic Syndromes; Hypertension

NCT ID: NCT00627380

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Condition: HIV Infections; Cardiovascular Disease; Insulin Resistance; HIV Lipodystrophy; The Metabolic Syndrome

NCT ID: NCT00656851

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Condition: HIV-1

NCT ID: NCT01771562

Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue

Condition: Lipodystrophy

NCT ID: NCT00647946

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

Condition: HIV Infections

NCT ID: NCT02191332

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Condition: HIV-1 Infections

NCT ID: NCT01074931

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Condition: HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00192621

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

Condition: HIV Infections

NCT ID: NCT00433992

Exercise and Pioglitazone for HIV-Metabolic Syndromes

Condition: HIV Infections; Type 2 Diabetes; Obesity; HIV; AIDS; Cardiovascular Disease; Lipodystrophy

NCT ID: NCT00639457

Cohort of Young Adults Infected With HIV Since Birth or During Childhood

Condition: HIV Infection; Young Adult

NCT ID: NCT01269632

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Condition: Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS); Human Immunodeficiency Virus Infections

NCT ID: NCT00294164

Observational Data Analysis in EuroSIDA (MK-0518-058)

Condition: HIV-1 Infections

NCT ID: NCT01078233

BASTA Study on STI in HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00310245

Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)

Condition: HIV-1 Infections

NCT ID: NCT01078246

Endothelial Dysfunction as a Risk Factor in HIV Study

Condition: HIV Infections

NCT ID: NCT00039663

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Condition: HIV Infections

NCT ID: NCT00389402

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005106

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Condition: HIV Infections

NCT ID: NCT00001137

Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS

Condition: HIV Infections; Fatigue; HIV Positive; AIDS; Healthy Volunteer; HV

NCT ID: NCT00106795

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Condition: HIV Infections

NCT ID: NCT00335686

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Condition: HIV Infections

NCT ID: NCT00120185

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122551

Long-Term Supervised Treatment Interruption in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00118677

Strategy for Maintenance of HIV Suppression With Elvitegravir + Darunavir/Ritonavir in Children

Condition: HIV Infection

NCT ID: NCT02383108

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00140751

Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

Condition: Mild Cognitive Impairment

NCT ID: NCT02572323

Evaluation of Albuminuria HIV-Infected Patients

Condition: HIV-Associated Focal Segmental Glomerulosclerosis; HIV-Associated Collapsing Glomerulopathy; Proteinuria; Albuminuria; Renal Tubular Toxicity

NCT ID: NCT00524992

The First Failure Study

Condition: HIV; HIV Infections

NCT ID: NCT01118871

Omega-3 Supplementation and Depression Clinical Trial

Condition: Depressive Symptoms

NCT ID: NCT01614249

ALCAR Prophylaxis Study

Condition: HIV Infections; Distal Symmetric Polyneuropathy

NCT ID: NCT00225160

Egrifta Replacement and Sleep Disordered Breathing

Condition: Lipodystrophy

NCT ID: NCT01788462

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Condition: HIV Infections; Coronary Artery Disease; Non-Alcoholic Fatty Liver Disease

NCT ID: NCT00889577

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895